Safety Efforts in Pediatric Drug Development
Author: Conor D. Byrne
Publisher: Nova Science Publishers
Release Date: May 21, 2010
This work focuses on the safety efforts being implemented in paediatric drug development. It also evaluates the impact of Best Pharmaceuticals for Children Act (BPCA) on labelling drugs for paediatric use and the process by which the labelling was changed, and illustrates the range of diseases treated by the drugs studied under BPCA.